Value Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
CS
Value Partners's XBI Position: Q2 2016 in Review
Value Partners held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2016 at 8,600 shares worth $465K. The position accounts for 0.29% of the portfolio, ranked #20.
Value Partners first reported a position in XBI in Q1 2016 and has held it in 2 quarters since. 201 funds tracked by Wall St. Rank hold XBI as of Q2 2016.
- Value Partners held 8,600 shares of State Street SPDR S&P Biotech ETF worth $465K as of Q2 2016.
- Value Partners left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2016.
- State Street SPDR S&P Biotech ETF made up 0.29% of Value Partners's portfolio in Q2 2016, its #20 holding.
- Value Partners first reported a position in State Street SPDR S&P Biotech ETF in Q1 2016 and has held it in 2 quarters since.
- 201 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2016.
Based on Value Partners's 13F filing for Q2 2016, filed 12 Aug 2016.